Draught Beer Market Size, Industry Share And Growth Analysis For 2024-2030: Grand View Research Inc.

 Draught Beer Market Growth & Trends

The global draught beer market size is anticipated to reach 59.39 billion by 2030, exhibiting a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc.The global market is driven by a rising demand for flavorful and lower alcohol beverages. Consumers are increasingly seeking unique taste experiences and craft beer varieties, contributing to the market's growth. This trend is fueled by broadening purchasing power, especially among younger generations, leading to more frequent visits to pubs and bars where draught beer is a popular choice.

Another significant driver is the growing trend of socializing and dining out. Draught beer is often associated with social gatherings, sports events, and leisure activities, enhancing its appeal. There is also increasing awareness about the potential health benefits of moderate beer consumption, such as reducing cholesterol levels and improving kidney health, which is driving the demand for draught beer.

The rising interest in craft beers and the trend of beer connoisseurship have propelled the demand for specialty and unique draught beer varieties. Consumers are seeking novel taste experiences, driving growth in this segment. Additionally, the resurgence of the hospitality and tourism industries post-pandemic has led to an increase in on-premise consumption of draught beer in bars, pubs, restaurants, and entertainment venues, further fueling the market.

Manufacturers are revolutionizing draught beer with innovations focused on quality, sustainability, and consumer experience. Nitro technology creates smoother textures, while smart taps and digital pour systems ensure precise control over beer flow and freshness. Customization options allow consumers to adjust carbonation and flavor, while eco-friendly kegs reduce environmental impact.

In March 2023, HEINEKEN USA Inc. unveiled Heineken Silver, a light lager with low carbs and calories. This beer features 4% alcohol by volume (ABV), with each 12-ounce serving containing just 3.2 grams of carbs and 95 calories. It is made with malted barley, water, and the company’s proprietary A Yeast. It is brewed to deliver a full-bodied flavor without the bitterness often associated with other lagers.

 Request a free sample copy or view report summary: Draught Beer Market Report

Draught Beer Market Report Highlights

• Keg draught beer accounted for a share of over 63.82% of the global revenues in 2023. Keg draft beer offers superior quality control compared to other packaging formats like bottles or cans. Breweries place importance on their brewing mechanism and ensure that the beer is kept under optimal conditions, such as temperature and pressure, from the brewery to the tap. Additionally, the standardized keg sizes facilitate easy storage, transportation, and use with existing tap systems, thereby enhancing operational efficiency and reducing waste. This combination of quality preservation, convenience, and cost-effectiveness drives the preference for keg beer in the draught market.
• Super premium draught beer is anticipated to grow at a CAGR of 6.9% from 2024 to 2030. The rise of the gastropub and upscale casual dining sectors has significantly contributed to the market's growth. These establishments often prioritize offering a curated selection of draught beers that complement their gourmet food offerings, enhancing the overall dining experience. The ambiance and service quality in such venues aligns well with the expectations of super-premium beer consumers, who are willing to pay a premium for a superior product served in an appropriate setting.
• Commercial use of draught beer accounted for a share of over 87% of the global revenues in 2023 due to its significant presence in bars, pubs, and restaurants, where draught beer is a staple offering. The primary driver is the desire for a premium and differentiated beverage experience in commercial settings such as bars, restaurants, and entertainment venues. Draught beer offers a fresher and more flavorful option compared to bottled or canned beer, providing establishments with a competitive edge in attracting and retaining customers who seek high-quality beverages.
• Draught beer manufactured through microbreweries is anticipated to grow at a CAGR of 6.3% from 2024 to 2030. Microbreweries frequently offer a wide range of beer styles and flavors, appealing to diverse tastes. Draught beer allows them to rotate their offerings more easily, keeping their selection fresh and exciting for customers.
• Europe market held a share of 44.56% of the global market in 2023. Europe has a long-standing tradition of beer consumption, with many countries having their own unique beer cultures. Draught beer is often preferred for its freshness and taste, especially in countries like Germany, Belgium, and the UK.

Access Press release@ https://www.grandviewresearch.com/press-release/global-draught-beer-market

Draught Beer Market Segmentation

Grand View Research has segmented the global draught beer market based on product, category, end user, type, and region.

Draught Beer Type Outlook (Revenue, USD Million, 2018 - 2030)

• Keg Beer
• Cask Beer

Draught Beer Category Outlook (Revenue, USD Million, 2018 - 2030)

• Super Premium
• Premium
• Regular

Draught Beer End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Commercial Use
• Home Use

Draught Beer Production Outlook (Revenue, USD Million, 2018 - 2030)

• Macro Breweries
• Microbreweries

Draught Beer Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Spain
  • Italy
  • France
  • Ireland
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
• Central & South America
  • Brazil

List of Key Players in the Draught Beer Market

• Anheuser-Busch InBev
• Boston Beer Company
• Heineken International B.V.
• Anadolu Efes
• Asahi Group Holdings, Ltd.
• Molson Coors Beverage Company
• China Resources Snow Breweries
• Carlsberg
• New Belgium Brewing Company
• Castel Frères
• Constellation Brands, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biomass Power Market To Reap Over $203.61 Billion In Revenues By End Of 2030: Grand View Research Inc.

 Biomass Power Market Growth & Trends

The global biomass power market size is expected to reach USD 203.61 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.3% from 2024 to 2030. The growing concerns about Greenhouse Gas (GHG) emissions have resulted in favorable policies and regulations for renewable energy, which has been the key factor driving the growth of this market. The COVID-19 pandemic has hampered the market growth globally owing to the disruptions in the supply chain, which resulted in delays for some projects. The power demand has declined from commercial and industrial end-users in the non-essential category due to the closure of operations during the lockdown.

These factors have resulted in delays in the construction of new biomass power plants and reduced power supply from existing biomass power plants. Solid biofuel has emerged as the dominant feedstock segment in the market owing to its easy availability. Moreover, it is simpler to use than liquid biofuel and biogas in power generation applications. The combustion technology segment accounted for the largest market share in 2021, in terms of revenue. The growth of this segment can be attributed to lower costs of combustion technology than anaerobic digestion and gasification technologies. Europe has emerged as the major regional market owing to the presence of supportive policies and plans, coupled with the announcement of the phasing-out of coal-based power plants by the leading European countries, such as the U.K., Germany, and France.

Request a free sample copy or view report summary: Biomass Power Market Report

Biomass Power Market Report Highlights

• In terms of revenue, the solid biofuel segment accounted for the dominant revenue share in 2023 and is projected to expected further over the forecast period
• Germany dominated the Europe regional market and accounted for the maximum revenue share in 2023
• The high rate of depletion of fossil fuels in the Europe region is creating ample growth opportunities for this market
• The European Union has set a target to fulfill a significant portion of its energy requirements from renewable sources
• The focus of governments of different countries of the region on reducing carbon emissions also creates ample opportunities for the market
• Some of the major strategic initiatives undertaken by vendors in the biomass power market include M&A & R&D activities, overseas business expansions, and strategic collaborations among the market participants

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biomass-power-market

Biomass Power Market Segmentation

Grand View Research has segmented the global biomass power market report based on feedstock, technology, and region

Biomass Power Technology Outlook (Revenue, USD Million; Volume, Million MWh, 2018 - 2030)

• Combustion
• Gasification
• Anaerobic Digestion

Biomass Power Feedstock Outlook (Revenue, USD Million; Volume, Million MWh, 2018 - 2030)

• Solid Biofuel
• Liquid Biofuel
• Biogas

Biomass Power Regional Outlook (Revenue, USD Million; Volume, Million MWh, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • UK
• Asia Pacific
  • China
  • India
  • Thailand
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of the Biomass Power Market

• Mitsubishi Heavy Industries, Ltd.
• Suez
• Xcel Energy Inc.
• Ramboll Group A/S
• Babcock & Wilcox Enterprises, Inc.
• Ørsted A/S
• Ameresco
• General Electric
• Veolia
• Vattenfall

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Inventory Management Software Market Competitive Insight and Key Drivers 2024 to 2030: Grand View Research Inc.

 Inventory Management Software Market Growth & Trends

The global inventory management software market size is expected to reach USD 5.08 billion by 2030 and grow at a CAGR of 6.7% from 2024 to 2030, according to a report by Grand View Research Inc. The inventory management software market is experiencing robust growth, driven by the increasing need for businesses to optimize supply chains, reduce costs, and enhance operational efficiency across various industries such as retail, manufacturing, healthcare, and logistics. The rapid expansion of e-commerce, technological advancements, and a focus on supply chain optimization are key drivers helping market growth.

Cloud-based solutions are increasingly popular due to their scalability, flexibility, and cost-effectiveness. These solutions allow businesses to manage inventory across multiple locations in real-time without the need for significant IT infrastructure investment. Cloud-based systems can be easily updated and maintained by the service provider, reducing the burden on in-house IT teams. They also offer enhanced accessibility, enabling users to access the software from any device with an internet connection, which is particularly beneficial for businesses with remote or distributed teams.

Mobile-friendly inventory management software enables managers to access and update inventory data from any location using smartphones or tablets, significantly enhancing flexibility and responsiveness. This capability is crucial for businesses with distributed operations or field teams, as it allows for real-time inventory tracking, immediate adjustments, and quick decision-making. Mobile solutions also facilitate better communication among team members and departments, ensuring that everyone has access to up-to-date information. This increased mobility and accessibility help businesses respond swiftly to market demands, manage resources more effectively, and maintain optimal inventory levels, ultimately leading to improved customer satisfaction and streamlined operations.

Supply chain optimization is a critical factor driving the adoption of inventory management software. Businesses are focusing on optimizing their supply chains to enhance efficiency, reduce costs, and improve customer satisfaction. Inventory management software plays a crucial role in this by offering advanced tools for demand forecasting, stock level management, and supplier coordination, ensuring that inventory levels are maintained optimally to meet customer demands without overstocking. In addition, regulatory compliance is vital, especially for industries handling sensitive data, such as healthcare and finance. Regulations such as GDPR in Europe and HIPAA in the U.S. mandate strict data protection and privacy measures. Inventory management software helps businesses adhere to these regulations by ensuring data accuracy, security, and traceability, reducing the risk of non-compliance penalties and building customer trust. By integrating compliance features and optimizing supply chain operations, inventory management software supports businesses in achieving operational excellence and regulatory adherence.

Request a free sample copy or view report summary: Inventory Management Software Market Report

Inventory Management Software Market Report Highlights

• The order management segment is anticipated to observe a CAGR of 7.8% during the forecast period. The rise of omnichannel retail strategies, where businesses sell through multiple channels (online, in-store, mobile), necessitates robust order management solutions that can integrate and synchronize orders from various sources to ensure a smooth customer experience
• The cloud segment is anticipated to observe a CAGR of 7.2% during the forecast period. Cloud-based systems can be accessed from any device with an internet connection, providing real-time inventory visibility and management capabilities from anywhere. This is crucial for businesses with multiple locations or remote teams, enhancing operational flexibility and responsiveness
• Small and medium-sized enterprises (SMEs) are anticipated to observe a CAGR of 7.2% during the forecast period. SMEs benefit from inventory management software that easily integrates with other business systems such as accounting, CRM, and e-commerce platforms. This seamless integration streamlines operations and provides a comprehensive view of business processes
• The retail segment is anticipated to observe a CAGR of 8.1% during the forecast period. The rapid growth of e-commercehas significantly increased the need for efficient inventory management systems. Retailers must handle large volumes of diverse products, manage multiple sales channels, and ensure timely fulfillment of online orders. Inventory management software helps streamline these processes, ensuring accurate stock levels and efficient order processing
• Asia Pacific region is expected to grow with the fastest CAGR of 7.9% from 2024 to 2030. Small and medium-sized enterprises (SMEs) are expanding rapidly in the Asia Pacific region. These businesses require cost-effective and scalable inventory management solutions to manage their operations efficiently and compete in the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-inventory-management-software-market

Global Inventory Management Software Market Segmentation

Grand View Research has segmented the global inventory management software market based on application, deployment, organization size, end use, and region:

Inventory Management Software Application Outlook (Revenue, USD Million, 2018 - 2030)

• Inventory Control & Tracking
• Order Management
• Scanning and Barcoding
• Asset Management
• Others

Inventory Management Software Deployment Outlook (Revenue, USD Million, 2018 - 2030)

• Cloud-based
• On-premises

Inventory Management Software Organization Size Outlook (Revenue, USD Million, 2018 - 2030)

• Small And medium-size enterprises
• Large enterprises

Inventory Management Software End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Retail
• E-commerce
• Healthcare
• Transportation and Logistics
• Manufacturing
• Others

Inventory Management Software Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa

Key players in Inventory Management Software Market

• Oracle Corportation
• SAP SE
• Microsoft Corporation
• IBM Corporation
• Manhattan Associates
• Epicor
• Zoho Corporation
• Fishbowl
• NetSuite
• DataLogic
• NCR Corporation
• Intuit, Inc.
• Acumatica, Inc.
• Lightspeed
• Revel Systems
• Archon Systems

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Factoring Services Market Outlook & Future Forecast Report Till 2030

 Factoring Services Market Growth & Trends

The global factoring services market size is expected to reach USD 8,188.67 billion by 2030, exhibiting a CAGR of 10.5% from 2024 to 2030, according to a new study by Grand View Research, Inc. The increasing demand for quick and hassle-free financing sources among Micro, Small, and Medium Enterprises (MSMEs) is driving market growth. Factoring services help businesses secure working capital loans and mitigate credit risks. Furthermore, the integration of Artificial Intelligence (AI) and machine learning is anticipated to enhance fraud risk identification, streamline underwriting processes, provide operational savings, and simplify payment applications. Fintech companies and banks have embraced these technologies to develop innovative products and maintain competitiveness in the market.

Since many factoring companies and other lenders have adopted disintegrated data architecture, the use of Application Programming Interface (API), File Transfer Protocol (FTP), or other types of protocols may not be suitable for all kinds of factoring operations. RPA helps businesses automate many processes and become more efficient because it does not necessitate backend coding and helps reduce difficulties associated with code-based data integrations. Furthermore, low-code applications are in high demand because they enable organizations to deploy robust apps that can be easily customized to the organization's needs while saving time, money, and errors in the operation.

Many Business-to-Consumer (B2C) transactions and payment methods, including cheques, are being replaced with electronic alternatives. Digitizing accounts receivable processes helps reduce printing costs and boosts employee profits. Numerous enterprises prefer on-premises deployment of accounts receivable solutions for complete control over infrastructure, assets, and business records. This preference is especially strong in the healthcare and BFSI sectors due to the critical nature of data across these industries. These factors are expected to drive the demand for automation in the factoring services market.

Request a free sample copy or view report summary: Factoring Services Market Report

Factoring Services Market Report Highlights

• Based on category, the international segment is expected to register a CAGR of 11.0% from 2024 to 2030. International factoring service providers bridge helps in bridging the gap by extending credit against foreign receivables, offering clients extra capital to foster business growth and handle expenses. Consequently, international factoring emerges as an essential tool for businesses seeking global expansion while upholding financial stability
• Based on type, the non-recourse segment is expected to register a CAGR of 10.8% from 2024 to 2030. Non-recourse factoring enables business expansion by permitting companies to onboard new clients and scale their activities without raising credit risk exposure. This flexibility in client acquisition and the capacity to capitalize on growth prospects are key drivers behind the growing preference for non-recourse factoring
• The non-banking financial institution segment is expected to register a CAGR of 11.9% from 2024 to 2030. Non-banking financial institutions provide adaptable and personalized factoring solutions, unlike conventional banking systems. NBFIs can customize terms, pricing structures, advance rates, and service levels to align with the specific preferences and circumstances of factoring businesses. This flexibility empowers customers to select arrangements that precisely meet their business needs
• North America is expected to register a CAGR of 10.0% from 2024 to 2030. In North America, factoring companies are honing their focus on delivering specialized services tailored to niche markets like transportation, staffing, and advertising. This strategic specialization enables these companies to gain deeper insights into the distinct requirements and obstacles faced by their clients, thereby offering customized financing solutions and additional value-added services

Access Press Release@ https://www.grandviewresearch.com/press-release/global-factoring-services-market

Factoring Services Market Segmentation

Grand View Research has segmented the global factoring services market based on category, type, financial institution, end-use, and region:

Factoring Services Category Outlook (Revenue, USD Billion, 2018 - 2030)

• Domestic
• International

Factoring Services Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Recourse
• Non-recourse

Factoring Services Financial Institution Outlook (Revenue, USD Billion, 2018 - 2030)

• Banks
• Non-banking Financial Institutions

Factoring Services End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Manufacturing
• Transport & Logistics
• Information Technology
• Healthcare
• Construction
• Staffing
• Others

Factoring Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico 
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Belgium
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa

List of Key Players in the Factoring Services Market

• altLINE (The Southern Bank Company)
• Barclays Bank PLC
• BNP Paribas
• China Construction Bank Corporation
• Deutsche Factoring Bank
• Eurobank
• Factor Funding Co.
• Hitachi Capital (UK) PLC
• HSBC Group
• ICBC China
• Kuke Finance
• Mizuho Financial Group, Inc.
• RTS Financial Service, Inc.
• Société Générale S.A.
• TCI Business Capital

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Coil Coatings Market Top Players, Segments, Cost Structure, Demand, Sales | 2030 Forecast

 Coil Coatings Market Growth & Trends

The global coil coatings market is anticipated to reach USD 4390.9 million by 2030, exhibiting a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The growth is attributed to the growing demand for these products from the construction industry, which includes both residential and commercial sectors. Coil coatings are widely used for roofing, cladding, and insulation of buildings, infrastructure, and industrial facilities.

Polyester resins are the most widely used in coil coating and typically do not contain trifunctional hydroxyl building blocks but instead utilize diols such as neopentyl glycol, propylene glycol, butane diol, or 1,6 hexane diol. The diacids used in these resins can be a combination of linear aliphatic diacids along with an aromatic diacid or their dianhydride. These resins are formulated to be rapidly cured at high temperatures and are often crosslinked with an aminoplast crosslinker such as melamine or blocked isocyanate.

Within the automotive sector, coil coating on aluminum parts is pivotal for enhancing the visual appeal and lifespan of vehicle components through superior corrosion resistance and vibrant, enduring color finishes. This process, which applies paint, anodizing, liquid, or powder coatings to precoated aluminum coils, is critical for the durability and weather resistance of exterior panels, trim, and structural elements. The automotive industry's move toward lighter materials for better fuel efficiency has made aluminum and effective coating methods increasingly important. Additionally, the rising demand for electric vehicles (EVs) is anticipated to propel the demand for aluminum coil coating products.

The overall market is expected to witness significant growth in emerging economies such as India, China, and Indonesia. This growth is attributed to the boom in the global construction industry and increasing demand for coil coatings from durable goods, motor vehicles, and industrial maintenance applications. Asia is expected to remain a prominent consumer and observe the fastest gains, in terms of production, in the coming years. In addition, the increasing tariff on heavy-duty equipment, automotive products, and other U.S.-originating goods is expected to positively impact the market share of regional manufacturers and raise the production of automotive OEMs (original equipment manufacturer) and heavy-duty equipment, thereby, augmenting the demand for coil coatings in the region.

Request a free sample copy or view report summary: Coil Coatings Market Report

Coil Coatings Market Report Highlights

• Plastisols witnessed the fastest growth rate of more than 4.4%, owing to their large-scale use due to their possession of notable strengths in terms of abrasion resistance, flexibility, and ability to form thick films.
• Aluminum witnessed the fastest CAGR of approximately 4.1% due to rising investment in the construction industry which is expected to propel the demand for aluminum coil coating.
• North America region witnessed the fastest growth rate of 5.7% due to increasing demand for aluminum and steel coils in different end-use industries in the region.
• The stringent regulations by the U.S. EPA, OSHA (Occupational Safety and Health Administration), the European Union (EU), and other regional agencies across the world are expected to restrain the growth of the market over the forecast period.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-coil-coatings-market

Coil Coatings Market Segmentation

Grand View Research has segmented the global coil coatings market based on basis of resin, application, end-use and region:

Coil Coatings Resin Outlook (Volume, Kilotons, Revenue, USD Million, 2018 - 2030)

• Polyester
• Fluoropolymer
• Siliconized Modified Polyesters (SMP)
• Plastisols
• Other Resins

Coil Coatings Application Outlook (Volume, Kilotons, Revenue, USD Million, 2018 - 2030)

• Steel
• Aluminum

Coil Coatings End Use Outlook (Volume, Kilotons, Revenue, USD Million, 2018 - 2030)

• Building & Construction
• Transportation
• Consumer Appliances
• Other End-uses

Coil Coatings Regional Outlook (Volume, Kilotons, Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
• Central & South America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa

List of Key Players in the Coil Coatings Market

• PPG Industries, Inc
• The Sherwin-Williams Company
• Akzo Nobel N.V.
• DuPont
• BASF SE
• Henkel AG & Co. KGaA
• Kansai Nerolac Paints Limited
• Axalta Coating Systems
• Continental Coatings
• JSW Paints
• Nippon Paints Holdings Co., Ltd.
• Blygold
• HUEHOCO

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nuclear Medicine Market to Reflect Robust Expansion During 2024-2030: Grand View Research Inc.

 Nuclear Medicine Market Growth & Trends

The global nuclear medicine market size is expected to reach USD 34.51 billion by 2030, registering a CAGR of 11.69% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer & thyroid is anticipated to drive market growth. The impending approval of multiple radiopharmaceutical therapeutics during the forecast period will be a major driver for the market. For instance, in March 2022, Novartis AG received approval for Pluvicto (Lu 177) for the treatment of adult patients with prostate cancer.

According to the Pan American Health Organization (PAHO), in 2022, globally around 20 million new cases of cancer are estimated to be diagnosed, and around 10 million deaths occurred due to this disease. Factors like changing lifestyle, unhealthy diet, and less awareness about oral hygiene in low and middle-income countries is the most common cause of the prevalence of cancer.

Increasing adoption of nuclear medicine products in diagnosis and the approval of new generators to help increase the supply of radionuclides is expected to drive growth. For instance, in November 2021, EZAG received the Brazilian Health Authority Regulatory Agency’s (ANVISA) approval for GalliaPharm in Brazil. It is a gallium-68 generator used to extract the positron-emitting isotope of gallium from a source of decaying germanium-68 for making G68 dotatate injection. This is the first and only gallium generator approved for pharmaceutical use in Brazil. The approval of such products contributes to the market growth in developing markets.

In light of the COVID-19 pandemic, the market was moderately impacted. A survey was conducted for reactor-based medical isotopes by International Atomic Energy Agency (IAEA) during the second quarter of 2020 to assess the continuity of the supply chain during the COVID-19 crisis. It was revealed that major producers continued with production in line with IAEA safety standards, as their operations were categorized as essential by their respective governments.

Request a free sample copy or view report summary: Nuclear Medicine Market Report

Nuclear Medicine Market Report Highlights

• By product type, the SPECT segment held the largest share of the diagnostics market due to low cost, high accuracy, and wide usage in different applications.
• The PET segment is expected to grow lucratively over the forecast period due to the approval & launch of new products such as PYLARIFY PET imaging agent for prostate cancer.
• By application, the oncology segment dominated the market in 2023.
• North America dominated the market with a share of 42.96% in 2023, owing to increased awareness about current treatment therapies, favorable reimbursement policies, and improved patient affordability.
• The Asia Pacific region is expected to be the fastest-growing region considerably in the future due to the rising prevalence of chronic diseases, rising geriatric population, and approval of new products during the forecast period.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nuclear-medicines-market

Nuclear Medicine Market Segmentation

Grand View Research has segmented the global nuclear medicine market on the basis of on product, application, end-use, and region:

Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostics
  • SPECT
    • TC-99m
    • TL-201
    • GA-67
    • I-123
    • Others
  • PET
    • F-18
    • SR-82/RB-82
    • PYLARIFY (piflufolastat F 18)
    • Illuccix (gallium Ga 68 gozetotide)
    • Others
  • Therapeutics
    • Alpha Emitters
      • RA-223
      • Others
    • Beta Emitters
      • I-131
      • Y-90
      • SM-153
      • Re-186
      • Lu-177
      • Others
    • Brachytherapy
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192
      • Others

Nuclear Medicine Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology
  • SPECT
  • PET
  • Therapeutic Applications
• Neurology
• Oncology
• Thyroid
  • SPECT
  • Therapeutic Applications
• Lymphoma
• Bone Metastasis
  • SPECT
  • Therapeutic Applications
• Endocrine Tumor
• Pulmonary Scans
• Urology
• Other

Nuclear Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Diagnostic Centers
• Others

Nuclear Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

List of Key Players in the Nuclear Medicine Market

• GE Healthcare
• Jubilant Life Sciences Ltd
• Nordion (Canada), Inc.
• Bracco Imaging S.P.A
• The institute for radioelements (IRE)
• NTP Radioisotopes SOC Ltd.
• The Australian Nuclear Science and Technology Organization
• Eczac?ba??-Monrol
• Lantheus Medical Imaging, Inc
• Eckert & Ziegler
• Mallinckrodt
• Cardinal Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemistry, Manufacturing And Control Services Outsourcing Market Set to Witness an Uptick during 2024 to 2030: Grand View Research Inc.

 Chemistry, Manufacturing, And Control Services Outsourcing Market Growth & Trends

The global chemistry, manufacturing and control services outsourcing market size is anticipated to reach USD 15.16 billion by 2030 and is projected to grow at a CAGR of 6.72% from 2024 to 2030, according to a new report by Grand View Research, Inc. Stringent regulatory requirements, increasing R&D investments, and growing need for cost-efficient manufacturing solutions are key factor driving market growth potential. Moreover, complexity of drug development, technological advancements in biologics and personalized medicine, and biopharmaceutical companies focusing on core competencies are another key factors positively impacting the market growth.

The incorporation of state-of-the-art technologies such as automation, artificial intelligence, continuous manufacturing, and digital analytics serves to enhance precision, reduce costs, and accelerate production capabilities. For instance, AI and machine learning applications in quality control and predictive maintenance are expected to reduce operational costs by 20-30%. AI and machine learning algorithms offers predictive analytics for process optimization, quality control, and troubleshooting, reducing time and cost in drug development. Automation in manufacturing processes, including robotics and continuous manufacturing, improves production efficiency, minimizes human error, and enhance product quality. In addition, advancements in digitalization, such as electronic lab notebooks (ELNs) and laboratory information management systems (LIMS), streamline data management and regulatory compliance, assisting seamless information flow and traceability. These advancements enable CMC service providers to offer enhanced quality and heightened reliability services compliant to complex demands of modern biopharmaceuticals including biologics and personalized medicines. The integration of advanced solutions is expected to further propel the market growth and competitiveness of the market.

Stringent regulatory scenario in several economies is anticipated to boost the global CMC services outsourcing market. Regulatory agencies, such as the U.S. FDA, the EU EMA, and several other national regulatory authorities enforce strict standards to ensure the safety, efficacy, and quality of pharmaceuticals and biologics. These stringent regulations require thorough documentation, comprehensive testing, and robust quality control throughout the drug development and manufacturing process. Pharmaceutical and biotechnology companies often encounter difficulties in keeping abreast of the evolving regulatory landscape and the associated compliance costs resulting in outsourcing of CMC services to specialized service providers. Moreover, market participants offer critical support in areas such as regulatory submissions, stability studies, analytical method validation, GMP compliance and several others, thereby propelling the industry growth potential.

Request a free sample copy or view report summary: Chemistry, Manufacturing And Control Services Outsourcing Market Report

Chemistry, Manufacturing And Control Services Outsourcing Market Report Highlights

• Based on type, the finished drug formulation segment led market with the largest revenue share of 43.77% in 2023.High revenue share is attributed to increasing demand for specialized expertise in formulation development, stringent regulatory requirements for finished drug products, the growing complexity of drug formulations, and the need for cost-effective manufacturing solutions
• Based on service, the analytical testing segment is expected to grow at the fastest CAGR during the forecast period. Growing adoption of biologics and advanced therapeutics along with stringent regulatory guidelines requiring comprehensive analytical testing throughout drug development cycles are anticipated to boost segmental demand in the global market.
• Based on end use, the pharmaceutical segment led the market with the largest revenue share of 40.56% in 2023. Several pharmaceutical companies outsourcing CMC services to focus on R&D activities such as drug discovery and clinical development, and cost affordability. Moreover, surge in outsourcing trends, evolving regulatory landscape and demand for specialized expertise among pharmaceutical companies are driving the segment growth potential
• North America dominated the market with the largest revenue share of 47.3% in 2023. Several factors such as stringent regulatory requirements, technological advancements, significant R&D investment, and increasing demand for specialized services are key factors accelerating the regional market growth. In addition, strong presence of leading pharmaceutical and biotechnology companies and growing focus on development of advanced therapies further propels market expansion 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemistry-manufacturing-control-services-outsourcing-market

Chemistry, Manufacturing And Control Services Outsourcing Market Segmentation

Grand View Research has segmented the global chemistry, manufacturing and control services outsourcing market report based on type, service, end-use and region:

Chemistry, Manufacturing And Control Services Outsourcing Type Outlook (Revenue, USD Million, 2018 - 2030)

• API
  • Small Molecule
  • Large Molecule
• Finished Drug Formulation
  • Solid Dosage Forms
  • Semi-solid Dosage Forms
  • Liquid Dosage Forms
  • Others
• Medical Device

Chemistry, Manufacturing And Control Services Outsourcing Service Outlook (Revenue, USD Million, 2018 - 2030)

• Manufacturing Services
  • Clinical Manufacturing
  • Drug Product Development and Manufacturing
  • Fill Finish Manufacturing
  • Others
• Regulatory Services
  • Regulatory Consulting
  • Regulatory Submissions
  • Compliance Audits
  • Others
• Analytical Testing
  • Stability Testing
  • Method Development and Validation
  • Quality Control (QC) Testing
  • Bioanalytical Testing
  • Others
• Others

Chemistry, Manufacturing And Control Services Outsourcing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical Companies
• Biotechnological Companies
• Medical Device Companies
• Others

Chemistry, Manufacturing And Control Services Outsourcing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Chemistry, Manufacturing And Control Services Outsourcing Market

• Thermo Fisher Scientific
• ICON plc
• Catalent, Inc.
• Thermo Fisher Scientific Inc.
• Recipharm AB
• WuXi AppTec
• Jubilant Life Sciences
• Samsung Biologics
• Boehringer Ingelheim BioXcellence
• Evonik Industries AG
• Ardena Holding NV.
• Argonaut Manufacturing Services Inc.
• Bachem
• Siegfried Holding AG
• AbbVie Inc.
• Ajinomoto Bio-Pharma
• CordenPharma

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Autologous Cell Therapy Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 Autologous Cell Therapy Market Growth & Trends

The global autologous cell therapy market size is expected to reach USD 17.97 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 22.20% from 2024 to 2030. The growing burden of diseases and disorders such as cancer, neurodegenerative disorders, cardiovascular disorders, autoimmune disorders, and orthopedics are the factors driving the demand for the market. Likewise, the reduced risk of autologous cell therapy rejection is one of the important factors for market growth as these therapies are developed from patient-derived cells and support the regeneration of the damaged tissues in the body.

During the COVID-19 pandemic, the market has witnessed various challenges where patients were restricted to stay at home due to safety concerns. Some factors that affected the market growth are manufacturing hurdles and reduced patient inflow in hospitals. However, post-COVID-19 the market has witnessed the demand for the market with FDA clearance and all of the new advances in treating a wide range of disease indications.

In April 2020, Hope Biosciences, a clinical-stage biotechnology company announced the FDA clearance for a phase II clinical trial evaluating the efficacy & safety of HB-adMSCs (Hope Bioscience’ autologous, adipose-derived mesenchymal stem cells), to offer immune support against COVID-19. In June 2020, Chiesi Group and Holostem Terapie Avanzate mentioned the agreement for the transfer of the business branch Holoclar. The Holoclar is an autologous stem cell therapy for patients with ocular surface burns. It aims to allow both companies to focus on the strategic objective and accelerate procedures access for rare diseases.

Request a free sample copy or view report summary: Autologous Cell Therapy Market Report

Autologous Cell Therapy Market Report Highlights

• The cancer segment dominated the market and accounted for a share of 29.9% in 2023. According to the American Cancer Society, it is anticipated that 1,958,310 new instances of cancer and 609,820 fatalities due to the disease.
• The bone marrow segment held the largest share of 29.9% in 2023. The bone marrow in autologous cell therapy has been successfully used to treat different diseases.
• The academics & research segment held the largest share of 39.05% in 2023 and is anticipated to grow rapidly from 2024 to 2030.
• North America autologous cell therapy market accounted for 36.68% share in 2023. The market is highly competitive since most of the major market players such as BrainStorm Cell Therapeutics and Bristol Myers Squibb operate in this region.
• Asia Pacific autologous cell therapy market is anticipated to witness fastest growth over the forecast period. owing to the rising burden of diseases, strong research activities in autologous cell therapies, the presence of a well-established biotechnology sector, developing healthcare facilities, and growing awareness for cell therapies.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-autologous-cell-therapy-market-report

Autologous Cell Therapy Market Segmentation

Grand View Research has segmented the global autologous cell therapy market report based on application, source, end-use, and region:

Autologous Cell Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cancer
• Neurodegenerative disorders
• Cardiovascular disorders
• Autoimmune disorders
• Orthopedics
• Wound healing
• Others

Autologous Cell Therapy Source Outlook (Revenue, USD Million, 2018 - 2030)

• Bone Marrow
• Epidermis
• Mesenchymal stem cells
• Haematopoietic stem cells
• Chondrocytes
• Others

Autologous Cell Therapy End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Ambulatory Centers
• Academics & Research
• Others

Autologous Cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

List of Key Players of Autologous Cell Therapy Market

• BrainStorm Cell Therapeutics
• Holostem Terapie Avanzate S.R.L
• Pharmicell Co. Inc
• Opexa Therapeutics
• Caladrius Biosciences Inc
• S. Stem Cell Inc
• Lonza
• Bristol Myers Squibb
• Novartis
• Autolus therapeutics
• Tego Science
• Corning Incorporated
• Bio Elpida
• Vericel Corporation
• Catalent, Inc
• Sartorius AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Personalized Nutrition & Supplements Market Valuation to Reach $12.92 Billion by the end of 2030: Grand View Research Inc.

 U.S. Personalized Nutrition & Supplements Market Growth & Trends

The U.S. personalized nutrition & supplements market size is anticipated to reach USD 12.92 billion by 2030 and is projected to expand at a CAGR of 16.28% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing consumer health awareness and growing demand for retail nutrition products are expected to drive the market growth.

The impact of the COVID-19 has led to a decline in the growth rate of the U.S. personalized nutrition & supplements market. Owing to the lockdown norms across the globe, users were prevented from accessing clinics and stores, while professionals were compelled to halt testing on which the recommendations are based. Various organizations have recognized the importance of personalized nutrition in relation to COVID-19. For instance, in March 2020, the American Nutrition Association announced the launch of a resource hub for personalized nutrition and COVID-19. The portal contains a rapid review by the professional to educate healthcare professionals. This factor has impelled the growth of the market and is anticipated to propel exponentially over the forecast period.

In addition, the increasing incidence of lifestyle diseases, growing concerns about inadequate nutrition, and a large geriatric population are some of the key factors responsible for the rise in demand for retained nutrition products. With the increase in the incidence of various illnesses, U.S. citizens are adopting a healthy lifestyle to obtain optimum nutrition for preventing them. According to Diana Food, the COVID-19 pandemic shifted consumers' preference toward personalized nutrition. Thereby propelling the growth of the U.S. personalized nutrition & supplements market over the forecast period.

Moreover, supplements are highly regulated and monitored by officials. The purpose of the regulation is to increase consumer protection and ensure the fulfillment of labeling requirements by companies. The U.S. FDA regulated dietary ingredients and finished supplement products under conventional foods & drug products. Under the regulations, manufacturers and distributors of supplements are prohibited from marketing products that are misbranded or adulterated. Thereby, challenging the growth of the market over the forecast period.

Request a free sample copy or view report summary: U.S. Personalized Nutrition & Supplements Market Report

U.S. Personalized Nutrition & Supplements Market Report Highlights

• Based on ingredient, the vitamins segment held the largest market share of 26.89% in 2023 based on ingredients. Vitamin supplements provide an easy way to fill any nutrient gaps that people might have in their diets. On the other hand, herbals/botanic are anticipated to grow at the fastest CAGR over the forecast period.
• In 2023, the tablets/capsules segment is anticipated to dominate the market share for the dosage form segment. However, the liquid segment is expected to grow at the fastest CAGR of 17.53% over the forecast period driven by its easier customization by adding various dosages of different nutrients to develop a personalized mix.
• Based on age group, the adults segment dominated with the largest share in 2023 and is anticipated to grow at the fastest CAGR over the forecast period. This growth is attributed to the fact that several companies are providing a wide array of tailored supplements, including customized multivitamins, probiotics, and protein powders, designed to meet the unique nutritional needs of adults.
• In 2023, the supermarkets/hypermarkets is anticipated to dominate the market share for the distribution channel segment. However, the online pharmacies & e-commerce site segment is expected to grow at the fastest CAGR over the forecast period. Various factors such as price discounts, at-home delivery, and convenience in ordering are the key determinants of growth in the market.

Access Press Release@ https://www.grandviewresearch.com/press-release/us-personalized-nutrition-supplements-market-analysis

U.S. Personalized Nutrition & Supplements Market Segmentation

Grand View Research has segmented the U.S. personalized nutrition & supplements market on the basis of ingredients, dosage form, age group, and distribution channel:

U.S. Personalized Nutrition & Supplements Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

• Proteins & Amino Acid
• Vitamins
• Minerals
• Probiotics
• Herbal/Botanic
• Others

U.S. Personalized Nutrition & Supplements Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)

• Tablets/Capsules
• Liquids
• Powders
• Others

U.S. Personalized Nutrition & Supplements Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Pediatrics
• Adults
• Geriatric

U.S. Personalized Nutrition & Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Supermarkets/Hypermarkets
• Specialty Stores
• Retail Pharmacies
• Online Pharmacies & E-commerce Site

List of Key Players in the U.S. Personalized Nutrition & Supplements Market

• Viome Life Sciences, Inc.
• DSM Nutritional Products AG
• Thorne
• HUM Nutrition, Inc.
• GenoPalate Inc
• Pharmavite
• GNC Holdings, LLC
• The Vitamin Shoppe
• Nestlé Health Science (Nestlé)
• Baze Labs
• InVite Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Diagnostic Enzymes Market Estimated To Flourish By 2030: Grand View Research Inc.

 Diagnostic Enzymes Market Growth & Trends

The global diagnostic enzymes market size is expected to reach USD 6.27 billion by 2030, registering a CAGR of 5.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Request a free sample copy or view the report summary: Diagnostic Enzymes Market Report

Diagnostic Enzymes Market Report Highlights

• In 2023, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymesin living organisms
• The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population
• The clinical segment is the highest revenue-generating segment in 2023 owing to the increased focus on R&D
• The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market
• Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diagnostic-enzymes-market

Diagnostic Enzymes Market Segmentation

Grand View Research has segmented the global diagnostic enzymes market report based on type, application, product, and region:

Diagnostic Enzymes Type Outlook (Revenue, USD Million, 2018 - 2030)

• Taq Polymerase
• MMLV RT
• HIV RT
• Hot Start Taq Polymerase
• UNG
• RNase Inhibitors
• Bst Polymerase
• PCR Master Mix
• Lyophilized Polymerase
• T7 RNA Polymerase
• Cas9 Enzyme
• Acid Phosphatase
• Alanine Aminotransferase
• Alkaline phosphatase
• Amylase
• Angiotensin Converting Enzyme
• Aspartate Aminotransferase
• Cholinesterase
• Creatinine Kinase
• Gamma Glutamyl Transferase
• Lactate Dehydrogenase
• Renin
• Glucose Oxidase/Glucose Dehydrogenase
• Urease
• Lactate Oxidase
• Horseradish Peroxide
• Glutamate Oxidase
• Others

Diagnostic Enzymes Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes
• Oncology
• Cardiology
• Infectious Diseases
• Nephrology
• Autoimmune Diseases
• Others

Diagnostic Enzymes Product Outlook (Revenue, USD Million, 2018 - 2030)

• Molecular Enzymes
• Clinical Enzymes

Diagnostic Enzymes End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Clinical Laboratories
• Other End Users

Diagnostic Enzymes Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Diagnostic Enzymes Market

• Takara Bio, Inc.
• Promega Corporation
• Enzo Life Sciences, Inc.
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Creative Enzyme
• Hoffmann-La Roche Ltd.
• Solis BioDyne.
• Ambliqon A/S.
• Yashraj Biotechnology Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.